EFP releases updated and expanded dossier on periodontal disease
The EFP has published a revised version of its extensive dossier on periodontal disease, to provide periodontal professionals, general dentists, and other health professionals with the latest information and insight.
JCP Digest: Periodontal therapy – with or without adjunctive systemic antimicrobials – can have positive effect on metabolic status
Periodontitis is an inflammatory disease that may contribute to increasing the risk of insulin resistance, type-2 diabetes, and cardiovascular disease. In addition, periodontitis has been associated with metabolic syndrome (MetS).
Finalists for EFP Research prize have been selected after record number of submissions
The three finalists for the EFP Research Prize in Periodontology, which will be awarded at the EuroPerio9 congress in Amsterdam on June 22, have been selected.
JCP Digest: Study shows possibility of lifelong tooth retention in patients with aggressive periodontitis
Aggressive periodontitis (AgP) is usually treated with mechanical debridement (sometimes with adjunctive antibiotics) but there have been few studies on long-term tooth survival in patients with the generalised form of this disease.
EuroPerio9 ambassadors highlight the attractions of the Amsterdam congress
With 10,000 people expected to register for EuroPerio9 in Amsterdam in June, there will be 10,000 individual reasons for attending.
EuroPerio9 will host global presentation of new classification of periodontal and peri-implant diseases
One of the key sessions at EuroPerio9 will be the formal presentation to the global periodontal and dental community of the new classification system for periodontal and peri-implant diseases.